Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Orphan Medical Xyrem Central Pharmacy Will List Prescribers Under DEA Rule

This article was originally published in The Pink Sheet Daily

Executive Summary

A Drug Enforcement Administration rule will require pharmacies dispensing products containing gamma hydroxybutyrate such as Xyrem to compile the names of the prescribing practicioner. Xyrem is distributed through a single pharmacy.
Advertisement

Related Content

Orphan Medical Xyrem Planned sNDA Will Aim For First-Line Narcolepsy Claim
Orphan Medical Xyrem Planned sNDA Will Aim For First-Line Narcolepsy Claim

Topics

Advertisement
UsernamePublicRestriction

Register

PS061022

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel